Recent studies have introduced serum uric acid (UA) as a potential risk factor for developing diabetes, hypertension, stroke, and cardiovascular diseases. e value of elevated levels of UA in serum as a risk factor for diabetes development is still under scrutiny. Recent data suggest that clearance of UA is being reduced with increase in insulin resistance and UA as a marker of prediabetes period. However, confl icting data related to UA in serum of patients with Type  diabetes prompted us to study the urine/serum ratio of UA levels (USRUA) in these patients and healthy controls. All subjects included in the study were free of evidence of hepatitis B or C viral infection or active liver and kidney damage. Patients receiving drugs known to infl uence UA levels were also excluded from this study. Analysis of glucose and uric acid were performed on Dade Behring analyzer using standard IFCC protocols. Interestingly, our data demonstrated about . fold higher USRUA values in diabetic patients as compared to control subjects. Furthermore, there was a trend of correlation of USRUA value with the blood glucose levels in diabetic patients, which was more prominent in diabetic men than in women. With aging, levels of uric acid increased in serum of diabetic patients, and this eff ect was also more profound in male than in female diabetics. In conclusion, this study showed signifi cantly elevated USRUA levels in patients with Type  diabetes, a negative USRUA correlation with the blood glucose levels in diabetic patients, and an eff ect of sex and age on the uric acid levels. Since literature data suggest a strong genetic eff ect on UA levels, it would be pertinent to perform further, possibly genetic studies, in order to clarify gender and ethnic differences in UA concentrations.
Introduction
For some time, it has been recognized that serum uric acid (UA) is positively associated with serum glucose levels in healthy subjects () . Recent studies have demonstrated that UA levels are higher in subjects with prediabetes and early Type  diabetes then in healthy controls (,) . Furthermore, an elevated serum UA level was found to increase chances for developing Type  diabetes in individuals with impaired glucose tolerance () . Hyperuricemia has been also added to the set of metabolic abnormalities associated with insulin resistance and/or hyperinsulinemia in metabolic syndrome (-) . An elevated UA levels, as reported, often precedes the development of obesity () , hyperinsulinemia (-) , and diabetes (-) . In addition, uric acid has been implicated in the development of metabolic syndrome () and hypertension () . However, hyperuricemia is not always found in diabetic individuals. Conflicting data exist about UA levels in Type  diabetes, as low levels were found in diabetic patients, while elevated serum UA is a feature of hyperinsulinemia and impaired glucose tolerance () . Although several studies have implicated the role of UA in progression of prediabetes to diabetes, studies related to UA levels in diabetes development are controversial and deserve further analysis. Therefore, in this study we have analyzed and examined potential role of UA as a biomarker for impaired glucose metabolism and diabetes progression by analyzing serum and urine levels of UA in Type  diabetic patients in Bosnia and Herzegovina (BH). In addition, here we also examined eff ects of glucose control, gender, and age on USRUA levels in diabetic patients.
Materials and Methods

Patients
In this study we have analyzed UA levels in a group of  patients diagnosed with Type  diabetes mellitus and  healthy controls. All human subjects involved in this study were patients of General hospital in Sarajevo, BH. All research involving human subjects and material derived from human subjects in this study was done in accordance with the ethical recommendations and practices of the Sarajevo General Hospital and complied with ethical principles outlined in World Medical Association Declaration of Helsinki -Ethical Principles for Medical Research Involving Human Subjects (initiated in June , last amendment in October ). Subjects included in this study were free of evidence of hepatitis B or C viral infection or active liver and kidney damage. Clinical Diagnosis of Type  Diabetes Mellitus Type  DM was clinically diagnosed by standardized clinical examination conducted by specialist of Internal Medicine. All subjects underwent medical history and clinical examination. Criteria for selection of patients included in this study was that the history of Type  diabetes was present for more than fi ve years. Under criteria of IDF, diabetes mellitus was diagnosed when fasting plasma glucose levels were higher than , mmol/l and postprandial serum glucose more than , mmol/. All patients had abdominal obesity (waist circumference more than  cm in women and  cm in men), following atherogenic dyslipidemia profi le (triglycerides > , mmol/l, HDL < , mmol/l), and controlled blood pressure levels. More than half of diabetic patients had some diabetic complications, often polyneuropathy and microangiopathy, but renal function was normal. Diabetic patients were on standard drug therapy of  mg Metformine twice daily. Control subjects were of approximately same age (range of - years), but with normal glucose-tolerance test (fasting plasma glucose less than , mmol/l, and two hours postprandial glycaemia less than , mmol/l). ey had no abdominal obesity as clinical criteria for insulin resistance. Sample Analysis Blood samples taken for the analysis were obtained from patients and subjects in fasting conditions from antecubital vein into siliconized tubes (BD Vacutainer Systems, Plymouth, UK). UA analyses were carried out in fresh samples. Analysis of glucose and UA in serum and urine were performed using glucose oxidase and uricase/peroxidase method, respectively, on Dade Behring analyzer. Standard IFCC protocols were used for all analyses. e USRUA ratio was calculated by dividing concentration of UA (μmol/L) in urine with its concentration in serum. Statistical Analysis Statistical analysis of the results from this study was done using SPSS . for Windows. Data are presented as mean ± SEM. Statistical signifi cance was set as p<,.
Results
Our study analyzed the USRUA levels in a group of  patients diagnosed with Type  diabetes mellitus and  adequate controls. Strikingly, as shown in Figure  , the USRUA values for diabetic patients were about , fold higher than in control subjects. Similar signifi cant diff erence in USRUA values (p<,) was demonstrated in both, female and male diabetic patients, as compared to their corresponding controls (data not shown).
Our data also demonstrated a trend in correlation of USRUA values with the blood glucose levels in diabetic patients, which was more prominent in male than in female patients ( Figure  ).
As shown in Figure  , there was a correlation between serum and urinary UA levels in diabetic patients. Interestingly, with aging, levels of UA increased in serum of diabetic patients. As demonstrated in Figure  , there was a correlation between diabetic patients' age and UA levels in serum, which was even more profound in male than in female diabetic patients ( Figure  ).
Discussion
Variations in uric acid levels have been increasingly associated with insulin resistance, hyperinsulinemia, and diabetes (-, ) . Diabetic patients who are hyperuricemic appear to be at increased risk for developing diabetic complications, especially renal (,) and cardiovascular disease () . In Type  diabetes, hyperuricemia seems to be associated with the insulin-resistance syndrome, impaired glucose tolerance, and an early onset of nephropathy, while hypouricemia is associated with nonadequate metabolic control, hyperfi ltration, and a late onset of overt nephropathy (, ) . Uric acid, although one of the major antioxidants in circulation () , can induce oxidative stress in a variety of cells including vascular smooth muscle cells () and thus, mediate progression of cardiovascular disease (, ) . e pathogenic mechanism appears to involve decreased nitric oxide (NO) bioavailability in vascular smooth muscle and endothelial cells and direct scavenging of NO by uric acid () . Decrease in endothelial NO production by uric acid, has been also associated with endothelial dysfunction and insulin resistance (, ) . In addition, uric acid has been implicated in the development of hypertension () and elevated levels of uric acid has been reported particularly in newly diagnosed hypertension () . Hyperuricemia is also closely linked to the various components of the metabolic syndrome () and represents a possible link between uric acid levels and cardiovascular morbidity and mortality () . A possible link of UA levels and Type  diabetes incidence has been recently reported in different ethnic groups, including Austrian (), Dutch (), Chinese () , and Japanese population () . Until now, the uric acid levels have rarely been analyzed in diabetic patients in BH and this is one of the fi rst studies in which uricemia was evaluated in these patients. In our study UA levels were measured in both, serum and urine samples, and then urine/serum ratio of uric acid levels was calculated and compared between Type  diabetic patients and control subjects. Patients receiving drugs known to infl uence UA levels were excluded from the analysis.
Our results demonstrated a profound increase in uric acid urine/serum ratios in Type  diabetic patients as compared to healthy controls. is is in line with data published in previous studies in which hyperuricemia has been associated with the higher risk for developing impaired glucose tolerance and Type  diabetes (, , , ). Here we also show a positive correlation between serum and urine UA levels in diabetic patients. Oral antidiabetic drug therapy used in this study had no eff ect on urine/serum ratio of UA in diabetic patients. Interestingly, our data suggest a trend of negative correlation between USRUA values and serum glucose levels, which was more profound in male than in female diabetic patients. ese results complemented previous study in Austrian men in which the correlation between serum UA and fasting glucose levels was also negative () , while study in Japanese men did not fi nd a signifi cant correlation between serum UA and glucose levels () . Based on our results, it appears that in male patients with inadequate glucose control (higher blood glucose levels), the USRUA values were lower than in patients with lower blood glucose levels. This is in line with previous reports, where an eff ect of sex on UA levels in relation to glucose control was also observed in diabetic patients () . However, the eff ect of gender on UA levels in diabetics is still controversial. Recently, Kramer and Muhlen () reported that although UA level predicted incident Type  diabetes in both sexes, their further analysis, stratifi ed by glucose tolerance status, showed that UA predicted Type  diabetes in women with impaired fasting glucose but not in men. Here we demonstrated an eff ect of aging on serum UA in diabetic patients, and there was a positive correlation between diabetic patients' age and UA levels in serum, particularly in diabetic men. Serum UA levels were signifi cantly higher in older male diabetic patients, while similar correlation was not observed in regards to urinary UA levels. us, our data suggest that with aging UA levels are increasing in serum of diabetic men, probably due to impaired UA clearance in these patients. Interestingly, in female diabetic patients, there was no eff ect of age or glucose control on UA levels in both, serum and urine. Previous studies reported that hyperglicemia was a risk factor for hyperuricemia (, ) and that an elevation of serum UA concentration increased the risk of Type  diabetes () . is was complemented with our results, which demonstrated that the USRUA values were higher in diabetic patients than in controls. Insulin resistance may be the linking between elevated glucose and UA levels, but we (data not shown) and others () did not find a significant correlation between these parameters in patients with Type  diabetes. Interestingly, our data demonstrated signifi cant positive correlation between USRUA and serum glucose levels in men diagnosed with Type  diabetes, as compared to diabetic women who participated in this study. is is in line with recent report, which has demonstrated that the inverse association between diabetes (or HbAc level ≥ ) and serum UA levels was signifi cantly stronger in men than in women () . In general, our results demonstrated no effect of sex on uric acid levels in serum and urine in both control and diabetic patients. Although there was a trend of increased UA levels in males as compared to females (data not shown), this diff erence was not signifi cant. is is in line with the recent report in which serum UA levels were analyzed in much higher number of people (about ), and found an increased incidence of hyperuricemia in males as compared to females () . Since estrogen promotes uric acid excretion (), this could explain higher incidence of hyperuricemia in men and increased levels of serum UA in postmenopausal women. is may also explain, at least partially, our fi nding that serum levels of UA in diabetic patients increased signifi cantly with aging. In addition, there is evidence for a strong genetic infl uence on serum UA levels, with heritability estimates up to  () . Furthermore, recent study by Kolz et al. () identifi ed nine loci that are associated with serum UA levels, with profound gender-specific effects of specific alleles on uric acid level regulation. Therefore, it appears that there is a strong genetic eff ect on UA levels and in order to clarify gender and ethnic diff erences in UA concentrations in diabetic patients, it would be pertinent to perform more studies of genetic variations that infl uence UA levels.
Conclusion
In summary, this study showed signifi cantly elevated urine/serum ratio of uric acid in patients with Type  diabetes, as compared to healthy control subjects. is is in line with some previous studies, which suggest a possible link between UA levels and diabetes. Interestingly, serum UA levels were increased in Type  diabetic patients and this phenomenon seemed to be more profound in male diabetic patients, who also demonstrated more prominent eff ect of glucose control on UA clearance than their female counterparts. Since, to our knowledge, this is one of the fi rst studies addressing prevalence of hyperuricemia in BH and its role in diabetes progression, more emphasis should be put on this risk factor for developing metabolic and cardiovascular disease in clinical practices in our country. Additional genetic studies addressing gender and ethno specifi c eff ects on UA levels in Type  diabetic patients appear also to be justifi ed. us, considering the potential link of elevated urine/serum ratio of uric acid with insulin resistance, impaired glucose tolerance, and progression to diabetes, further research should attempt to determine whether it is eff ective to utilize USRUA levels as a predictor in prevention of Type  diabetes.
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